|
|
 |
|
Viewing report
|
|
 |
 |
Directory of Clinical Research Companies in India
CYGNUS Business Consulting & Research, Nov 2010, Pages: 150
India is fast emerging as a favoured destination for clinical trials by global pharmaceutical and biotech companies that are looking for partnerships or setting up new operations. Two major reasons for its popularity are: easy access and availability of a large, diverse and therapy-naïve population with vast gene pool and lower cost of technical services resulting into lower per patient trial cost. India also has the advantage of having a large pool of highly trained physicians, nurses, and technical personnel; numerous world-class medical facilities; broadly developed information technology infrastructure; a favourable IPR environment (post signing the WTO agreement) and use of English as the primary business and medical language. The Indian contract research market stood at USD0.9 billion in 2009 and is expected to touch USD3.4 billion in 2012, reflecting a CAGR of over 55.0% (2009–2012). The major companies involved in Clinical research in India have a wide range of services to offer.
The directory of ‘Clinical Research Companies in India’ serves as a ready-reckoner for use by the industry globally – pharma and biotech companies, contract research companies, funding organisations and others. The companies profiled are involved in clinical research and support services. As it is an emerging market with most of the companies in the small to medium size range, the list may not be comprehensive. The CRO directory covers 69 companies and each profile includes details like description of the company, contact details of key personnel, areas of operation, clinical trial expertise and other information. The details have been obtained from published sources as of October 2010. All the companies are listed in alphabetical order. In order to facilitate access of key information on each company at a glance, a “Ready Reckoner” table is also provided at the beginning of the report.
|
 |
|
|